Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence (Q36936421)

17 August 2017

1 reference

title

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence (English)

1 reference

17 August 2017

1 reference

Hiremath S

1

1 reference

17 August 2017

Fergusson D

2

1 reference

17 August 2017

Doucette S

3

1 reference

17 August 2017

Mulay AV

4

1 reference

17 August 2017

Knoll GA

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

American Journal of Transplantation

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

10

1 reference

17 August 2017

2350-2360

1 reference

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

The burden of chronic kidney disease in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Posttransplant erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Systematic reviews: synthesis of best evidence for clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Meta-Analysis. Potentials and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Renal dysfunction complicating the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Chronic allograft nephropathy: pathogenesis and management of an important posttransplant complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Treatment of hypertension in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Management of cardiovascular disease in the renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Prevalence and management of anemia in renal transplant recipients: a European survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Anemia after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

Proteinuria after renal transplantation affects not only graft survival but also patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01928.X

10.1111/J.1600-6143.2007.01928.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference